These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Mutational analyses of AVPR2 gene in three Japanese families with X-linked nephrogenic diabetes insipidus: two recurrent mutations, R137H and deltaV278, caused by the hypermutability at CpG dinucleotides. Shoji Y; Takahashi T; Suzuki Y; Suzuki T; Komatsu K; Hirono H; Shoji Y; Yokoyama T; Kito H; Takada G Hum Mutat; 1998; Suppl 1():S278-83. PubMed ID: 9452109 [No Abstract] [Full Text] [Related]
29. Nephrogenic diabetes insipidus: close linkage with markers from the distal long arm of the human X chromosome. Knoers N; van der Heyden H; van Oost BA; Ropers HH; Monnens L; Willems J Hum Genet; 1988 Sep; 80(1):31-8. PubMed ID: 2843456 [TBL] [Abstract][Full Text] [Related]
30. Physiopathology and diagnosis of nephrogenic diabetes insipidus. Devuyst O Ann Endocrinol (Paris); 2012 Apr; 73(2):128-9. PubMed ID: 22503803 [TBL] [Abstract][Full Text] [Related]
31. Inheritance of mutations in the V2 receptor gene in thirteen families with nephrogenic diabetes insipidus. Knoers NV; van den Ouweland AM; Verdijk M; Monnens LA; van Oost BA Kidney Int; 1994 Jul; 46(1):170-6. PubMed ID: 7933835 [TBL] [Abstract][Full Text] [Related]
34. Vasopressin receptor mutations causing nephrogenic diabetes insipidus. Bichet DG; Turner M; Morin D Proc Assoc Am Physicians; 1998; 110(5):387-94. PubMed ID: 9756088 [TBL] [Abstract][Full Text] [Related]
35. Proposed cause of marked vasopressin resistance in a female with an X-linked recessive V2 receptor abnormality. Moses AM; Sangani G; Miller JL J Clin Endocrinol Metab; 1995 Apr; 80(4):1184-6. PubMed ID: 7714087 [TBL] [Abstract][Full Text] [Related]
36. Identification of mutations of the arginine vasopressin-neurophysin II gene in two kindreds with familial central diabetes insipidus. Heppner C; Kotzka J; Bullmann C; Krone W; Müller-Wieland D J Clin Endocrinol Metab; 1998 Feb; 83(2):693-6. PubMed ID: 9467595 [TBL] [Abstract][Full Text] [Related]
37. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus. Bichet DG; Razi M; Lonergan M; Arthus MF; Papukna V; Kortas C; Barjon JN N Engl J Med; 1988 Apr; 318(14):881-7. PubMed ID: 2965301 [TBL] [Abstract][Full Text] [Related]
38. [From genes to disease: from vasopressin-V2-receptor and aquaporine-2 to nephrogenic diabetes insipidus]. Knoers NV; Deen PM Ned Tijdschr Geneeskd; 2000 Dec; 144(50):2402-4. PubMed ID: 11145096 [TBL] [Abstract][Full Text] [Related]
39. Novel mutations in the V2 vasopressin receptor gene of patients with X-linked nephrogenic diabetes insipidus. Wenkert D; Merendino JJ; Shenker A; Thambi N; Robertson GL; Moses AM; Spiegel AM Hum Mol Genet; 1994 Aug; 3(8):1429-30. PubMed ID: 7987330 [No Abstract] [Full Text] [Related]
40. Type 2 vasopressin receptor gene, the gene responsible nephrogenic diabetes insipidus, maps to Xq28 close to the LICAM gene. Frattini A; Zucchi I; Villa A; Patrosso C; Repetto M; Susani L; Strina D; Redolfi E; Vezzoni P; Romano G Biochem Biophys Res Commun; 1993 Jun; 193(3):864-71. PubMed ID: 8323561 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]